Bravecto 250 mg (Fluralaner TABLET (CHEWABLE)) 250 MG

Bravecto 250 mg chewable tablets contain fluralaner, a parasiticide for oral use in dogs. This medication is designed to provide long-lasting protection against fleas and ticks, ensuring your pet's comfort and health.

Strength

250 MG

Pack Size

1/2/4

Manufacturer / TM Owner

INTERVET CANADA CORP

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Bravecto 250 mg chewable tablets are primarily used for the treatment and prevention of flea and tick infestations in dogs. Fluralaner, the active ingredient, works to eliminate these parasites and provide extended protection. Pet owners often ask, 'What is Bravecto used for?' This medication is particularly effective for managing and preventing flea and tick bites, which can cause discomfort and potential health issues for dogs.

Side Effects

Common effects of Bravecto 250 mg chewable tablets include reduced flea and tick activity within 8 hours of administration. Many pet owners notice a significant decrease in flea and tick infestations within the first 12 hours. The medication continues to work for up to 12 weeks, providing long-lasting protection against these parasites.

Precautions & Warnings

It is important to follow the dosage instructions provided by your veterinarian when administering Bravecto 250 mg chewable tablets. Ensure that the tablet is given as a whole and not broken into pieces. Always store the medication in a cool, dry place away from direct sunlight. Consult your veterinarian before using this medication if your dog has any pre-existing health conditions or is on other medications.

Avoid Interactions

Bravecto 250 mg chewable tablets may interact with other medications, so it is important to inform your veterinarian about any other treatments your dog is receiving. Avoid administering this medication with other parasiticides unless directed by a veterinarian. Always consult your veterinarian before combining Bravecto with other medications to ensure the safety and well-being of your pet.

Frequently Asked Questions

Bravecto 250 mg chewable tablets are used to treat and prevent flea and tick infestations in dogs.

Bravecto 250 mg chewable tablets provide protection against fleas and ticks for up to 12 weeks.

Consult your veterinarian before administering Bravecto 250 mg with other medications to avoid potential interactions.

If your dog shows signs of an adverse reaction, contact your veterinarian immediately for advice.

Store Bravecto 250 mg chewable tablets in a cool, dry place away from direct sunlight.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.